Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, RAPT Therapeutics Inc’s stock clocked out at $8.33, up 2.52% from its previous closing price of $8.12. In other words, the price has increased by $2.52 from its previous closing price. On the day, 0.42 million shares were traded. RAPT stock price reached its highest trading level at $8.58 during the session, while it also had its lowest trading level at $8.15.
Ratios:
To gain a deeper understanding of RAPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.41 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on February 22, 2024, Downgraded its rating to Neutral and sets its target price to $10 from $61 previously.
On February 21, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $42 to $10.
JP Morgan Downgraded its Overweight to Neutral on February 21, 2024, whereas the target price for the stock was revised from $35 to $15.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 05 ’24 when Brockstedt Dirk G. sold 898 shares for $22.78 per share. The transaction valued at 20,456 led to the insider holds 27,820 shares of the business.
HO WILLIAM sold 2,500 shares of RAPT for $54,200 on Dec 21 ’23. The Chief Medical Officer now owns 15,020 shares after completing the transaction at $21.68 per share. On Nov 28 ’23, another insider, HO WILLIAM, who serves as the Chief Medical Officer of the company, sold 1,500 shares for $13.72 each. As a result, the insider received 20,580 and left with 17,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RAPT now has a Market Capitalization of 289881504 and an Enterprise Value of 137908864.
Stock Price History:
Over the past 52 weeks, RAPT has reached a high of $27.35, while it has fallen to a 52-week low of $6.86. The 50-Day Moving Average of the stock is -1.64%, while the 200-Day Moving Average is calculated to be -49.42%.
Shares Statistics:
It appears that RAPT traded 1.40M shares on average per day over the past three months and 627260 shares per day over the past ten days. A total of 34.40M shares are outstanding, with a floating share count of 30.63M. Insiders hold about 11.99% of the company’s shares, while institutions hold 90.53% stake in the company. Shares short for RAPT as of 1713139200 were 3184129 with a Short Ratio of 2.28, compared to 1710460800 on 3297629. Therefore, it implies a Short% of Shares Outstanding of 3184129 and a Short% of Float of 12.3100005.
